Home › Hepatitis C › NCT06179498
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
Recruiting
A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment Among Young Adult People Who Inject Drugs
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Self report injecting drugs in the past month * Self report a primary injecting partner (currently inject drugs together) * HCV infection identified at partnering community-based clinical site
About the study
The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).
What is being tested
- Partner Navigation Intervention (behavioral)
Sponsor: University of California, San Francisco · Participants: 500 · Started: Mar 25, 2024
Contact the study team
- Meghan D Morris, MPH, PhD · Phone: 415-574-0651
Official record on ClinicalTrials.gov — NCT06179498
Locations in the U.S.
| California | University of California, San Francisco, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.